United States Healthcare Equipment & Supplies

ICU Medical Inc (ICUI)

Track

Track

ICU Medical Inc. experienced significant insider selling over the past ninety days, totaling approximately 2.38 million dollars in net value. Following a strong earnings report, executives including the COO and CIO offloaded shares. These ten transactions reflect a trend of divestment as the stock price climbed fifty-four percent recently.
Ticker: ICUI Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for ICU Medical Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.9
Woolson Daniel VP, GM-Infusion Capital Officer
Transaction date
Sale
Price
115.47
Quantity 32,055 -2.4%
Value US$164,807
2.9
DANIEL WOOLSON Officer Officer
Transaction date
Proposed sale
Price
439.61
Quantity 49,181
Value US$1,918,652
2.1
Sousa Ben Chief Information Officer Officer
Transaction date
Sale
Price
293.79
Quantity 15,685 +21.1%
Value US$4,593,061
2.1
BENJAMIN SOUSA Officer Officer
Transaction date
Proposed sale
Price
178.32
Quantity 1,000
Value US$100,000
3.3
Voigtlander Christian B. Chief Operating Officer Officer
Transaction date
Sale
Price
182.93
Quantity 1,000 -19.3%
Value US$100,000
3.3
FINNEY ELISHA W Non-Executive Director
Transaction date
Sale
Price
182.48
Quantity 1,000 -7.2%
Value US$100,000
3.3
CHRISTIAN VOIGTLANDER Officer Officer
Transaction date
Proposed sale
Price
182.93
Quantity 1,000
Value US$100,000
3.3
ELISHA W FINNEY Director Non-Executive Director
Transaction date
Proposed sale
Price
182.48
Quantity 1,000
Value US$100,000
3.3
ELISHA W FINNEY Director Non-Executive Director
Transaction date
Proposed sale
Price
182.48
Quantity 1,000
Value US$100,000
2.9
DANIEL WOOLSON Officer Officer
Transaction date
Proposed sale
Price
132.21
Quantity 2,123
Value US$280,685
2.9
Woolson Daniel President Officer
Transaction date
Sale
Price
132.21
Quantity 2,123 -8.6%
Value US$280,685
2.6
Sanzone Virginia Ruth VP, General Counsel Officer
Transaction date
Sale
Price
124.08
Quantity 2,447 -11.2%
Value US$303,624
2.6
VIRGINIA SANZONE Officer Officer
Transaction date
Proposed sale
Price
124.08
Quantity 2,447
Value US$303,624
2.0
Greenberg David C. Non-Executive Director
Transaction date
Sale
Price
122.91
Quantity 2,424 -23.3%
Value US$297,934
2.0
DAVID C GREENBERG Director Non-Executive Director
Transaction date
Proposed sale
Price
122.91
Quantity 2,424
Value US$297,934
2.9
DANIEL WOOLSON Officer Officer
Transaction date
Proposed sale
Price
152.35
Quantity 2,897
Value US$441,364
2.9
Woolson Daniel VP, GM-Infusion Capital Officer
Transaction date
Sale
Price
152.35
Quantity 2,897 -20.4%
Value US$441,364
2.6
VIRGINIA SANZONE Officer Officer
Transaction date
Proposed sale
Price
142.35
Quantity 930
Value US$132,381
3.3
ELISHA W FINNEY Director Non-Executive Director
Transaction date
Proposed sale
Price
140.42
Quantity 1,285
Value US$180,440
2.6
Sanzone Virginia Ruth VP, General Counsel Officer
Transaction date
Sale
Price
142.35
Quantity 930 -14.6%
Value US$132,381
3.3
FINNEY ELISHA W Non-Executive Director
Transaction date
Sale
Price
140.42
Quantity 1,285 -24.3%
Value US$180,440
2.0
Greenberg David C. Non-Executive Director
Transaction date
Purchase
Price
126.69
Quantity 598 +8.1%
Value US$75,760
2.0
Greenberg David C. Non-Executive Director
Transaction date
Purchase
Price
126.14
Quantity 602 +8.9%
Value US$75,938
4.0
Jain Vivek Chairman and CEO Executive Director
Transaction date
Purchase
Price
112.92
Quantity 19,551 +17.7%
Value US$2,207,761
4.0
Jain Vivek Chairman and CEO Executive Director
Transaction date
Purchase
Price
112.12
Quantity 2,378 +2.2%
Value US$266,613
2.6
VIRGINIA SANZONE Officer Officer
Transaction date
Proposed sale
Price
133.62
Quantity 700
Value US$93,537
2.6
Sanzone Virginia Ruth VP, General Counsel Officer
Transaction date
Sale
Price
133.62
Quantity 700 -9.9%
Value US$93,537
3.3
Voigtlander Christian B. Chief Operating Officer Officer
Transaction date
Sale
Price
128.50
Quantity 4,985 -45.0%
Value US$640,576
3.3
Voigtlander Christian B. Chief Operating Officer Officer
Transaction date
Sale
Price
131.00
Quantity 4,945 -47.3%
Value US$647,795
3.3
Voigtlander Christian B. Chief Operating Officer Officer
Transaction date
Sale
Price
130.00
Quantity 4,959 -50.3%
Value US$644,670
3.3
Voigtlander Christian B. Chief Operating Officer Officer
Transaction date
Sale
Price
130.03
Quantity 4,959 -53.5%
Value US$644,832
3.3
Voigtlander Christian B. Chief Operating Officer Officer
Transaction date
Sale
Price
133.00
Quantity 4,917 -57.0%
Value US$653,961
3.3
Voigtlander Christian B. Chief Operating Officer Officer
Transaction date
Sale
Price
137.11
Quantity 4,871 -61.3%
Value US$667,879
3.3
FINNEY ELISHA W Non-Executive Director
Transaction date
Sale
Price
138.92
Quantity 600 -15.6%
Value US$83,353
3.3
FINNEY ELISHA W Director Non-Executive Director
Transaction date
Proposed sale
Price
138.92
Quantity 600
Value US$83,353
3.3
Voigtlander Christian B. Chief Operating Officer Officer
Transaction date
Sale
Price
138.00
Quantity 5,555 -69.9%
Value US$766,614
3.3
Voigtlander Christian B. Chief Operating Officer Officer
Transaction date
Sale
Price
140.00
Quantity 5,555 -69.9%
Value US$777,700
2.1
Sousa Ben Officer Officer
Transaction date
Proposed sale
Price
137.36
Quantity 2,000
Value US$274,714
2.1
Sousa Ben Chief Information Officer Officer
Transaction date
Sale
Price
137.36
Quantity 2,000 -80.7%
Value US$274,714
3.3
Voigtlander Christian B. Chief Operating Officer Officer
Transaction date
Sale
Price
135.55
Quantity 5,555 -69.9%
Value US$752,977
3.3
Voigtlander Christian B. Chief Operating Officer Officer
Transaction date
Sale
Price
138.65
Quantity 5,556 -69.9%
Value US$770,324
3.3
Voigtlander Christian B. Officer Officer
Transaction date
Proposed sale
Price
138.65
Quantity 55,556
Value US$7,702,684
2.0
Greenberg David C. Director Non-Executive Director
Transaction date
Proposed sale
Price
143.66
Quantity 1,942
Value US$278,992
2.0
Greenberg David C. Non-Executive Director
Transaction date
Sale
Price
143.66
Quantity 1,942 -22.3%
Value US$278,992
4.0
VIVEK JAIN Officer; Director Executive Director
Transaction date
Proposed sale
Price
155.48
Quantity 1,373
Value US$213,474
4.0
Jain Vivek Chairman and CEO Executive Director
Transaction date
Planned sale
Price
155.48
Quantity 1,373 -1.3%
Value US$213,474
2.9
Woolson Daniel Officer Officer
Transaction date
Proposed sale
Price
156.25
Quantity 2,241
Value US$350,158
2.9
Woolson Daniel VP, GM-Infusion Capital Officer
Transaction date
Sale
Price
156.25
Quantity 2,241 -17.1%
Value US$350,158
4.0
VIVEK JAIN Officer; Director Executive Director
Transaction date
Proposed sale
Price
162.91
Quantity 12,000
Value US$1,954,933
4.0
Jain Vivek Chairman and CEO Executive Director
Transaction date
Planned sale
Price
163.96
Quantity 78 -0.1%
Value US$12,789
4.0
Jain Vivek Chairman and CEO Executive Director
Transaction date
Planned sale
Price
163.18
Quantity 8,250 -7.3%
Value US$1,346,223
4.0
Jain Vivek Chairman and CEO Executive Director
Transaction date
Planned sale
Price
162.29
Quantity 3,672 -3.1%
Value US$595,923
2.0
Greenberg David C. Director Non-Executive Director
Transaction date
Proposed sale
Price
158.11
Quantity 972
Value US$153,683
2.0
Greenberg David C. Non-Executive Director
Transaction date
Sale
Price
158.11
Quantity 972 -16.2%
Value US$153,683
3.3
Voigtlander Christian B. Chief Operating Officer Officer
Transaction date
Sale
Price
158.00
Quantity 1,430 -100.0%
Value US$225,936
3.3
Voigtlander Christian B. Chief Operating Officer Officer
Transaction date
Sale
Price
160.09
Quantity 206 -100.0%
Value US$32,979
3.3
Voigtlander Christian B. Chief Operating Officer Officer
Transaction date
Sale
Price
159.09
Quantity 7,513 -97.3%
Value US$1,195,212
3.3
Voigtlander Christian B. Chief Operating Officer Officer
Transaction date
Sale
Price
169.08
Quantity 1,962 -100.0%
Value US$331,726
3.3
Voigtlander Christian B. Officer Officer
Transaction date
Proposed sale
Price
171.00
Quantity 11,111
Value US$1,899,981
4.0
Jain Vivek Chairman and CEO Executive Director
Transaction date
Planned sale
Price
173.60
Quantity 1,239 -1.2%
Value US$215,087
4.0
Jain Vivek Chairman and CEO Executive Director
Transaction date
Planned sale
Price
172.76
Quantity 2,386 -2.2%
Value US$412,212
4.0
Jain Vivek Chairman and CEO Executive Director
Transaction date
Planned sale
Price
171.91
Quantity 4,147 -3.7%
Value US$712,905
4.0
Jain Vivek Chairman and CEO Executive Director
Transaction date
Planned sale
Price
170.75
Quantity 4,228 -3.6%
Value US$721,933
4.0
VIVEK JAIN Officer; Director Executive Director
Transaction date
Proposed sale
Price
171.84
Quantity 12,000
Value US$2,062,135
4.0
VIVEK JAIN Officer; Director Executive Director
Transaction date
Proposed sale
Price
178.46
Quantity 12,000
Value US$2,141,579
4.0
Jain Vivek Chairman and CEO Executive Director
Transaction date
Planned sale
Price
180.48
Quantity 788 -0.7%
Value US$142,219
4.0
Jain Vivek Chairman and CEO Executive Director
Transaction date
Planned sale
Price
179.16
Quantity 3,375 -3.1%
Value US$604,658
4.0
Jain Vivek Chairman and CEO Executive Director
Transaction date
Planned sale
Price
178.49
Quantity 3,681 -3.3%
Value US$657,021
4.0
Jain Vivek Chairman and CEO Executive Director
Transaction date
Planned sale
Price
177.50
Quantity 4,156 -3.6%
Value US$737,682
4.0
VIVEK JAIN Officer; Director Executive Director
Transaction date
Proposed sale
Price
163.46
Quantity 12,000
Value US$1,961,539
4.0
Jain Vivek Chairman and CEO Executive Director
Transaction date
Planned sale
Price
164.07
Quantity 3,805 -3.5%
Value US$624,298
4.0
Jain Vivek Chairman and CEO Executive Director
Transaction date
Planned sale
Price
163.59
Quantity 4,440 -4.1%
Value US$726,326
4.0
Jain Vivek Chairman and CEO Executive Director
Transaction date
Planned sale
Price
162.69
Quantity 3,755 -3.5%
Value US$610,916
2.9
Woolson Daniel Officer Officer
Transaction date
Proposed sale
Price
163.99
Quantity 2,502
Value US$410,303
2.9
Woolson Daniel VP, GM-Infusion Capital Officer
Transaction date
Sale
Price
163.22
Quantity 2,502 -16.0%
Value US$408,370
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-13 2026-08-13 S Sale
2.9
Woolson Daniel

VP, GM-Infusion Capital

Officer
32,055 -2.4%
115.47
US$164,807 		32,055 -2.4% 115.47 US$164,807
2026-08-13 2026-08-13 PrS Proposed sale
2.9
DANIEL WOOLSON

Officer

Officer
49,181
439.61
US$1,918,652 		49,181 439.61 US$1,918,652
2026-08-12 2026-08-12 S Sale
2.1
Sousa Ben

Chief Information Officer

Officer
15,685 +21.1%
293.79
US$4,593,061 		15,685 +21.1% 293.79 US$4,593,061
2026-08-12 2026-08-12 PrS Proposed sale
2.1
BENJAMIN SOUSA

Officer

Officer
1,000
178.32
US$100,000 		1,000 178.32 US$100,000
2026-08-11 2026-08-11 S Sale
3.3
Voigtlander Christian B.

Chief Operating Officer

Officer
1,000 -19.3%
182.93
US$100,000 		1,000 -19.3% 182.93 US$100,000
2026-08-11 2026-08-11 S Sale
3.3
FINNEY ELISHA W
Non-Executive Director
1,000 -7.2%
182.48
US$100,000 		1,000 -7.2% 182.48 US$100,000
2026-08-11 2026-08-11 PrS Proposed sale
3.3
CHRISTIAN VOIGTLANDER

Officer

Officer
1,000
182.93
US$100,000 		1,000 182.93 US$100,000
2026-08-11 2026-08-11 PrS Proposed sale
3.3
ELISHA W FINNEY

Director

Non-Executive Director
1,000
182.48
US$100,000 		1,000 182.48 US$100,000
2026-08-11 2026-08-11 PrS Proposed sale
3.3
ELISHA W FINNEY

Director

Non-Executive Director
1,000
182.48
US$100,000 		1,000 182.48 US$100,000
2026-05-22 2026-05-22 PrS Proposed sale
2.9
DANIEL WOOLSON

Officer

Officer
2,123
132.21
US$280,685 		2,123 132.21 US$280,685
2026-05-22 2026-05-22 S Sale
2.9
Woolson Daniel

President

Officer
2,123 -8.6%
132.21
US$280,685 		2,123 -8.6% 132.21 US$280,685
2026-05-15 2026-05-14 S Sale
2.6
Sanzone Virginia Ruth

VP, General Counsel

Officer
2,447 -11.2%
124.08
US$303,624 		2,447 -11.2% 124.08 US$303,624
2026-05-14 2026-05-14 PrS Proposed sale
2.6
VIRGINIA SANZONE

Officer

Officer
2,447
124.08
US$303,624 		2,447 124.08 US$303,624
2026-05-13 2026-05-12 S Sale
2.0
Greenberg David C.
Non-Executive Director
2,424 -23.3%
122.91
US$297,934 		2,424 -23.3% 122.91 US$297,934
2026-05-12 2026-05-12 PrS Proposed sale
2.0
DAVID C GREENBERG

Director

Non-Executive Director
2,424
122.91
US$297,934 		2,424 122.91 US$297,934
2025-11-25 2025-11-25 PrS Proposed sale
2.9
DANIEL WOOLSON

Officer

Officer
2,897
152.35
US$441,364 		2,897 152.35 US$441,364
2025-11-25 2025-11-25 S Sale
2.9
Woolson Daniel

VP, GM-Infusion Capital

Officer
2,897 -20.4%
152.35
US$441,364 		2,897 -20.4% 152.35 US$441,364
2025-11-12 2025-11-11 PrS Proposed sale
2.6
VIRGINIA SANZONE

Officer

Officer
930
142.35
US$132,381 		930 142.35 US$132,381
2025-11-12 2025-11-11 PrS Proposed sale
3.3
ELISHA W FINNEY

Director

Non-Executive Director
1,285
140.42
US$180,440 		1,285 140.42 US$180,440
2025-11-12 2025-11-11 S Sale
2.6
Sanzone Virginia Ruth

VP, General Counsel

Officer
930 -14.6%
142.35
US$132,381 		930 -14.6% 142.35 US$132,381
2025-11-12 2025-11-11 S Sale
3.3
FINNEY ELISHA W
Non-Executive Director
1,285 -24.3%
140.42
US$180,440 		1,285 -24.3% 140.42 US$180,440
2025-08-27 2025-08-27 B Purchase
2.0
Greenberg David C.
Non-Executive Director
598 +8.1%
126.69
US$75,760 		598 +8.1% 126.69 US$75,760
2025-08-27 2025-08-27 B Purchase
2.0
Greenberg David C.
Non-Executive Director
602 +8.9%
126.14
US$75,938 		602 +8.9% 126.14 US$75,938
2025-08-14 2025-08-14 B Purchase
4.0
Jain Vivek

Chairman and CEO

Executive Director
19,551 +17.7%
112.92
US$2,207,761 		19,551 +17.7% 112.92 US$2,207,761
2025-08-14 2025-08-14 B Purchase
4.0
Jain Vivek

Chairman and CEO

Executive Director
2,378 +2.2%
112.12
US$266,613 		2,378 +2.2% 112.12 US$266,613
2025-05-30 2025-05-30 PrS Proposed sale
2.6
VIRGINIA SANZONE

Officer

Officer
700
133.62
US$93,537 		700 133.62 US$93,537
2025-05-30 2025-05-30 S Sale
2.6
Sanzone Virginia Ruth

VP, General Counsel

Officer
700 -9.9%
133.62
US$93,537 		700 -9.9% 133.62 US$93,537
2025-05-28 2025-05-28 S Sale
3.3
Voigtlander Christian B.

Chief Operating Officer

Officer
4,985 -45.0%
128.50
US$640,576 		4,985 -45.0% 128.50 US$640,576
2025-05-28 2025-05-27 S Sale
3.3
Voigtlander Christian B.

Chief Operating Officer

Officer
4,945 -47.3%
131.00
US$647,795 		4,945 -47.3% 131.00 US$647,795
2025-05-23 2025-05-23 S Sale
3.3
Voigtlander Christian B.

Chief Operating Officer

Officer
4,959 -50.3%
130.00
US$644,670 		4,959 -50.3% 130.00 US$644,670
2025-05-23 2025-05-22 S Sale
3.3
Voigtlander Christian B.

Chief Operating Officer

Officer
4,959 -53.5%
130.03
US$644,832 		4,959 -53.5% 130.03 US$644,832
2025-05-21 2025-05-21 S Sale
3.3
Voigtlander Christian B.

Chief Operating Officer

Officer
4,917 -57.0%
133.00
US$653,961 		4,917 -57.0% 133.00 US$653,961
2025-05-21 2025-05-20 S Sale
3.3
Voigtlander Christian B.

Chief Operating Officer

Officer
4,871 -61.3%
137.11
US$667,879 		4,871 -61.3% 137.11 US$667,879
2025-05-20 2025-05-19 S Sale
3.3
FINNEY ELISHA W
Non-Executive Director
600 -15.6%
138.92
US$83,353 		600 -15.6% 138.92 US$83,353
2025-05-19 2025-05-19 PrS Proposed sale
3.3
FINNEY ELISHA W

Director

Non-Executive Director
600
138.92
US$83,353 		600 138.92 US$83,353
2025-05-19 2025-05-19 S Sale
3.3
Voigtlander Christian B.

Chief Operating Officer

Officer
5,555 -69.9%
138.00
US$766,614 		5,555 -69.9% 138.00 US$766,614
2025-05-19 2025-05-16 S Sale
3.3
Voigtlander Christian B.

Chief Operating Officer

Officer
5,555 -69.9%
140.00
US$777,700 		5,555 -69.9% 140.00 US$777,700
2025-05-15 2025-05-15 PrS Proposed sale
2.1
Sousa Ben

Officer

Officer
2,000
137.36
US$274,714 		2,000 137.36 US$274,714
2025-05-15 2025-05-15 S Sale
2.1
Sousa Ben

Chief Information Officer

Officer
2,000 -80.7%
137.36
US$274,714 		2,000 -80.7% 137.36 US$274,714
2025-05-15 2025-05-15 S Sale
3.3
Voigtlander Christian B.

Chief Operating Officer

Officer
5,555 -69.9%
135.55
US$752,977 		5,555 -69.9% 135.55 US$752,977
2025-05-15 2025-05-14 S Sale
3.3
Voigtlander Christian B.

Chief Operating Officer

Officer
5,556 -69.9%
138.65
US$770,324 		5,556 -69.9% 138.65 US$770,324
2025-05-14 2025-05-14 PrS Proposed sale
3.3
Voigtlander Christian B.

Officer

Officer
55,556
138.65
US$7,702,684 		55,556 138.65 US$7,702,684
2025-05-13 2025-05-13 PrS Proposed sale
2.0
Greenberg David C.

Director

Non-Executive Director
1,942
143.66
US$278,992 		1,942 143.66 US$278,992
2025-05-13 2025-05-13 S Sale
2.0
Greenberg David C.
Non-Executive Director
1,942 -22.3%
143.66
US$278,992 		1,942 -22.3% 143.66 US$278,992
2025-01-02 2025-01-02 PrS Proposed sale
4.0
VIVEK JAIN

Officer; Director

Executive Director
1,373
155.48
US$213,474 		1,373 155.48 US$213,474
2025-01-02 2025-01-02 PlS Planned sale
4.0
Jain Vivek

Chairman and CEO

Executive Director
1,373 -1.3%
155.48
US$213,474 		1,373 -1.3% 155.48 US$213,474
2024-12-06 2024-12-06 PrS Proposed sale
2.9
Woolson Daniel

Officer

Officer
2,241
156.25
US$350,158 		2,241 156.25 US$350,158
2024-12-06 2024-12-06 S Sale
2.9
Woolson Daniel

VP, GM-Infusion Capital

Officer
2,241 -17.1%
156.25
US$350,158 		2,241 -17.1% 156.25 US$350,158
2024-12-02 2024-12-02 PrS Proposed sale
4.0
VIVEK JAIN

Officer; Director

Executive Director
12,000
162.91
US$1,954,933 		12,000 162.91 US$1,954,933
2024-12-02 2024-12-02 PlS Planned sale
4.0
Jain Vivek

Chairman and CEO

Executive Director
78 -0.1%
163.96
US$12,789 		78 -0.1% 163.96 US$12,789
2024-12-02 2024-12-02 PlS Planned sale
4.0
Jain Vivek

Chairman and CEO

Executive Director
8,250 -7.3%
163.18
US$1,346,223 		8,250 -7.3% 163.18 US$1,346,223
2024-12-02 2024-12-02 PlS Planned sale
4.0
Jain Vivek

Chairman and CEO

Executive Director
3,672 -3.1%
162.29
US$595,923 		3,672 -3.1% 162.29 US$595,923
2024-11-27 2024-11-27 PrS Proposed sale
2.0
Greenberg David C.

Director

Non-Executive Director
972
158.11
US$153,683 		972 158.11 US$153,683
2024-11-27 2024-11-27 S Sale
2.0
Greenberg David C.
Non-Executive Director
972 -16.2%
158.11
US$153,683 		972 -16.2% 158.11 US$153,683
2024-11-27 2024-11-27 S Sale
3.3
Voigtlander Christian B.

Chief Operating Officer

Officer
1,430 -100.0%
158.00
US$225,936 		1,430 -100.0% 158.00 US$225,936
2024-11-26 2024-11-26 S Sale
3.3
Voigtlander Christian B.

Chief Operating Officer

Officer
206 -100.0%
160.09
US$32,979 		206 -100.0% 160.09 US$32,979
2024-11-26 2024-11-26 S Sale
3.3
Voigtlander Christian B.

Chief Operating Officer

Officer
7,513 -97.3%
159.09
US$1,195,212 		7,513 -97.3% 159.09 US$1,195,212
2024-11-26 2024-11-25 S Sale
3.3
Voigtlander Christian B.

Chief Operating Officer

Officer
1,962 -100.0%
169.08
US$331,726 		1,962 -100.0% 169.08 US$331,726
2024-11-25 2024-11-25 PrS Proposed sale
3.3
Voigtlander Christian B.

Officer

Officer
11,111
171.00
US$1,899,981 		11,111 171.00 US$1,899,981
2024-11-04 2024-11-01 PlS Planned sale
4.0
Jain Vivek

Chairman and CEO

Executive Director
1,239 -1.2%
173.60
US$215,087 		1,239 -1.2% 173.60 US$215,087
2024-11-04 2024-11-01 PlS Planned sale
4.0
Jain Vivek

Chairman and CEO

Executive Director
2,386 -2.2%
172.76
US$412,212 		2,386 -2.2% 172.76 US$412,212
2024-11-04 2024-11-01 PlS Planned sale
4.0
Jain Vivek

Chairman and CEO

Executive Director
4,147 -3.7%
171.91
US$712,905 		4,147 -3.7% 171.91 US$712,905
2024-11-04 2024-11-01 PlS Planned sale
4.0
Jain Vivek

Chairman and CEO

Executive Director
4,228 -3.6%
170.75
US$721,933 		4,228 -3.6% 170.75 US$721,933
2024-11-01 2024-11-01 PrS Proposed sale
4.0
VIVEK JAIN

Officer; Director

Executive Director
12,000
171.84
US$2,062,135 		12,000 171.84 US$2,062,135
2024-10-01 2024-10-01 PrS Proposed sale
4.0
VIVEK JAIN

Officer; Director

Executive Director
12,000
178.46
US$2,141,579 		12,000 178.46 US$2,141,579
2024-10-01 2024-10-01 PlS Planned sale
4.0
Jain Vivek

Chairman and CEO

Executive Director
788 -0.7%
180.48
US$142,219 		788 -0.7% 180.48 US$142,219
2024-10-01 2024-10-01 PlS Planned sale
4.0
Jain Vivek

Chairman and CEO

Executive Director
3,375 -3.1%
179.16
US$604,658 		3,375 -3.1% 179.16 US$604,658
2024-10-01 2024-10-01 PlS Planned sale
4.0
Jain Vivek

Chairman and CEO

Executive Director
3,681 -3.3%
178.49
US$657,021 		3,681 -3.3% 178.49 US$657,021
2024-10-01 2024-10-01 PlS Planned sale
4.0
Jain Vivek

Chairman and CEO

Executive Director
4,156 -3.6%
177.50
US$737,682 		4,156 -3.6% 177.50 US$737,682
2024-09-03 2024-09-03 PrS Proposed sale
4.0
VIVEK JAIN

Officer; Director

Executive Director
12,000
163.46
US$1,961,539 		12,000 163.46 US$1,961,539
2024-09-03 2024-09-03 PlS Planned sale
4.0
Jain Vivek

Chairman and CEO

Executive Director
3,805 -3.5%
164.07
US$624,298 		3,805 -3.5% 164.07 US$624,298
2024-09-03 2024-09-03 PlS Planned sale
4.0
Jain Vivek

Chairman and CEO

Executive Director
4,440 -4.1%
163.59
US$726,326 		4,440 -4.1% 163.59 US$726,326
2024-09-03 2024-09-03 PlS Planned sale
4.0
Jain Vivek

Chairman and CEO

Executive Director
3,755 -3.5%
162.69
US$610,916 		3,755 -3.5% 162.69 US$610,916
2024-08-30 2024-08-30 PrS Proposed sale
2.9
Woolson Daniel

Officer

Officer
2,502
163.99
US$410,303 		2,502 163.99 US$410,303
2024-08-30 2024-08-30 S Sale
2.9
Woolson Daniel

VP, GM-Infusion Capital

Officer
2,502 -16.0%
163.22
US$408,370 		2,502 -16.0% 163.22 US$408,370
Explore more

More insider trading research around ICU Medical Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America